GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,510,000 | -14.8% | 36,264 | -5.5% | 0.84% | -12.0% |
| Q1 2015 | $1,772,000 | +5.2% | 38,389 | -2.6% | 0.96% | +1.8% |
| Q4 2014 | $1,684,000 | -16.1% | 39,402 | -9.8% | 0.94% | -20.0% |
| Q3 2014 | $2,008,000 | -12.5% | 43,682 | +1.8% | 1.18% | -11.9% |
| Q2 2014 | $2,295,000 | -3.0% | 42,919 | -3.1% | 1.34% | -7.4% |
| Q1 2014 | $2,367,000 | -23.1% | 44,294 | -23.2% | 1.44% | -28.0% |
| Q4 2013 | $3,078,000 | +6.3% | 57,644 | -0.1% | 2.00% | -5.3% |
| Q3 2013 | $2,895,000 | -11.6% | 57,694 | -12.0% | 2.12% | -13.1% |
| Q2 2013 | $3,276,000 | – | 65,544 | – | 2.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
| KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
| NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
| EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
| Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
| Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
| Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
| Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
| P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |